Functional analysis of tumour necrosis factor-α-related apoptosis-inducing ligand (TRAIL):: cysteine-230 plays a critical role in the homotrimerization and biological activity of this novel tumoricidal cytokine

被引:21
作者
Trabzuni, D
Famulski, KS
Ahmad, M
机构
[1] King Faisal Specialist Hosp & Res Ctr, Dept Biol & Med Res, Lab Mol Apoptosis & Canc Therapy, Riyadh 11211, Saudi Arabia
[2] King Faisal Specialist Hosp & Res Ctr, Dept Biol & Med Res, Proteom Res Unit, Riyadh 11211, Saudi Arabia
关键词
glutathione S-transferase; soluble TNF alpha-related apoptosis-inducing ligand; sTRAIL; TdT-mediated dUTP nick end labelling;
D O I
10.1042/0264-6021:3500505
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have determined that the mutation of the cysteine-230 residue to either glycine or serine in TRAIL (tumour necrosis factor-a-related apoptosis-inducing ligand) results in the formation of a structurally incompetent dimer and a consequent loss of apoptotic activity. Similarly, chemical modification of the thiol residues present in both reduced and Zn2+-depleted trimer converts TRAIL into an inactive dimer. We postulate that cysteine-230 plays a critical role in homotrimerization of this tumoricidal cytokine.
引用
收藏
页码:505 / 510
页数:6
相关论文
共 18 条
[1]   Human ICE/CED-3 protease nomenclature [J].
Alnemri, ES ;
Livingston, DJ ;
Nicholson, DW ;
Salvesen, G ;
Thornberry, NA ;
Wong, WW ;
Yuan, JY .
CELL, 1996, 87 (02) :171-171
[2]   Safety and antitumor activity of recombinant soluble Apo2 ligand [J].
Ashkenazi, A ;
Pai, RC ;
Fong, S ;
Leung, S ;
Lawrence, DA ;
Masters, SA ;
Blackie, C ;
Chang, L ;
McMurtrey, AE ;
Hebert, A ;
DeForge, L ;
Koumenis, IL ;
Lewis, D ;
Harris, L ;
Bussiere, J ;
Koeppen, H ;
Shahrokh, Z ;
Schwall, RH .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (02) :155-162
[3]   Death receptors: Signaling and modulation [J].
Ashkenazi, A ;
Dixit, VM .
SCIENCE, 1998, 281 (5381) :1305-1308
[4]   2.8 Å resolution crystal structure of human TRAIL, a cytokine with selective antitumor activity [J].
Cha, SS ;
Kim, MS ;
Choi, YH ;
Sung, BJ ;
Shin, NK ;
Shin, HC ;
Sung, YC ;
Oh, BH .
IMMUNITY, 1999, 11 (02) :253-261
[5]   THE KILLER AND THE EXECUTIONER - HOW APOPTOSIS CONTROLS MALIGNANCY [J].
GREEN, DR ;
MARTIN, SJ .
CURRENT OPINION IN IMMUNOLOGY, 1995, 7 (05) :694-703
[6]  
Horvitz HR, 1999, CANCER RES, V59, p1701S
[7]   A unique zinc-binding site revealed by a high-resolution X-ray structure of homotrimeric Apo2L/TRAIL [J].
Hymowitz, SG ;
O'Connell, MP ;
Ultsch, MH ;
Hurst, A ;
Totpal, K ;
Ashkenazi, A ;
de Vos, AM ;
Kelley, RF .
BIOCHEMISTRY, 2000, 39 (04) :633-640
[8]   Triggering cell death: The crystal structure of Apo2L/TRAIL in a complex with death receptor 5 [J].
Hymowitz, SG ;
Christinger, HW ;
Fuh, G ;
Ultsch, M ;
O'Connell, M ;
Kelley, RF ;
Ashkenazi, A ;
de Vos, AM .
MOLECULAR CELL, 1999, 4 (04) :563-571
[9]   Programmed cell death in animal development [J].
Jacobson, MD ;
Weil, M ;
Raff, MC .
CELL, 1997, 88 (03) :347-354
[10]   Identification and molecular cloning of two novel receptors for the cytotoxic ligand TRAIL [J].
MacFarlane, M ;
Ahmad, M ;
Srinivasula, SM ;
FernandesAlnemri, T ;
Cohen, GM ;
Alnemri, ES .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (41) :25417-25420